Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis

Neurologic Clinics

Volumn 33, Issue 4, 2015, Pages 735-748

  Statland, Jeffrey M ^a   Barohn, Richard J ^a   McVey, April L ^a   Katz, Jonathan S ^a,b   Dimachkie, Mazen M ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis; Lou Gehrig disease; Lower motor neuron; Motor neuron disease; Upper motor neuron

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; MEDICAL HISTORY; MOTOR NEURON DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPINAL MUSCULAR ATROPHY; SYMPTOM ASSESSMENT; TREATMENT PLANNING; WEAKNESS; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; HISTORY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

AMYOTROPHIC LATERAL SCLEROSIS; DIAGNOSIS, DIFFERENTIAL; HISTORY, 20TH CENTURY; HUMANS; MOTOR NEURON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 84946471802     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2015.07.006     Document Type: Review

References (34)

1. Barohn R.J., Amato A.A. Pattern-recognition approach to neuropathy and neuronopathy. Neurol Clin 2013, 31(2):343-361.
2. Barohn R.J., Dimachkie M.M., Jackson C.E. A pattern recognition approach to patients with a suspected myopathy. Neurol Clin 2014, 32(3):569-593.
3. Statland J.M., Barohn R.J., Dimachkie M.M., et al. Primary lateral sclerosis. Neurol Clin 2015, in press.
4. Liewluck T., Saperstein D.S. Progressive muscular atrophy. Neurol Clin 2015, in press.
5. Wang C.H., Finkel R.S., Bertini E.S., et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 2007, 22(8):1027-1049.
6. Rhodes L.E., Freeman B.K., Auh S., et al. Clinical features of spinal and bulbar muscular atrophy. Brain 2009, 132(Pt 12):3242-3251.
7. Norris F., Shepherd R., Denys E., et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993, 118(1):48-55.
8. Jawdat O., Statland J.M., Barohn R.J., et al. Amyotrophic Lateral Sclerosis Regional Variant (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis). Neurol Clin 2015, in press.
9. Burrell J.R., Vucic S., Kiernan M.C. Isolated bulbar phenotype of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011, 12(4):283-289.
10. Hazan J., Fontaine B., Bruyn R.P., et al. Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p. Hum Mol Genet 1994, 3(9):1569-1573.
11. Martinez Murillo F., Kobayashi H., Pegoraro E., et al. Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology 1999, 53(1):50-56.
12. Zhai P., Pagan F., Statland J., et al. Primary lateral sclerosis: a heterogeneous disorder composed of different subtypes?. Neurology 2003, 60(8):1258-1265.
13. Rudnicki S., McVey A.L., Jackson C.E., et al. Symptom management and end-of-life care. Neurol Clin 2015, in press.
14. Mehta P., Antao V., Kaye W., et al. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011. MMWR Surveill Summ 2014, 63(Suppl 7):1-14.
15. Deenen J., Horlings C., Verschuuren J., et al. The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. J Neuromuscul Dis 2015, 2:73-85.
16. Abhinav K., Stanton B., Johnston C., et al. Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology 2007, 29(1-2):44-48.
17. Chio A., Calvo A., Moglia C., et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011, 82(7):740-746.
18. Rechtman L., Jordan H., Wagner L., et al. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontotemporal Degener 2015, 16(1-2):65-71.
19. Chio A., Mora G., Calvo A., et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 2009, 72(8):725-731.
20. Traxinger K., Kelly C., Johnson B.A., et al. Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011. Neurol Clin Pract 2013, 3(4):313-320.
21. Traynor B.J., Codd M.B., Corr B., et al. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999, 52(3):504-509.
22. Giordana M.T., Ferrero P., Grifoni S., et al. Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. Neurol Sci 2011, 32(1):9-16.
23. Lambert E.H., Mulder D.W. Electromyographic studies in amyotrophic lateral sclerosis. Mayo Clinic 1957, 32:441-446.
24. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases. J Neurol Sci 1994, 124(Suppl):96-107.
25. Ross M.A., Miller R.G., Berchert L., et al. Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group. Neurology 1998, 50(3):768-772.
26. de Carvalho M., Dengler R., Eisen A., et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008, 119(3):497-503.
27. Brooks B.R., Miller R.G., Swash M., et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(5):293-299.
28. Chancellor A.M., Slattery J.M., Fraser H., et al. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993, 240(6):339-346.
29. del Aguila M.A., Longstreth W.T., McGuire V., et al. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003, 60(5):813-819.
30. Kollewe K., Mauss U., Krampfl K., et al. ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci 2008, 275(1-2):69-73.
31. Gordon P.H., Cheng B., Katz I.B., et al. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology 2009, 72(22):1948-1952.
32. Miller R.G., Mitchell J.D., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2012, (3). CD001447.
33. Bradley W.G., Anderson F., Bromberg M., et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology 2001, 57(3):500-504.
34. Miller R.G., Jackson C.E., Kasarskis E.J., et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009, 73(15):1227-1233.